Prevention of COVID-19 Completed Phase 3 Trials for Lopinavir (DB01601)

Also known as: Prevention of COVID19

IndicationStatusPhase
DBCOND0128932 (Prevention of COVID-19)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04364022Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in SwitzerlandPrevention